Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-25-006007
Filing Date
2025-04-30
Accepted
2025-04-30 16:30:20
Documents
25
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20250617xdef14a.htm   iXBRL DEF 14A 2112079
2 GRAPHIC tmb-20250617xdef14a001.jpg GRAPHIC 14201
3 GRAPHIC tmb-20250617xdef14a002.jpg GRAPHIC 4301
4 GRAPHIC tmb-20250617xdef14a003.jpg GRAPHIC 6349
5 GRAPHIC tmb-20250617xdef14a004.jpg GRAPHIC 58633
6 GRAPHIC tmb-20250617xdef14a007.jpg GRAPHIC 46711
7 GRAPHIC tmb-20250617xdef14a018.jpg GRAPHIC 69192
8 GRAPHIC tmb-20250617xdef14a019.jpg GRAPHIC 59541
9 GRAPHIC tmb-20250617xdef14a020.jpg GRAPHIC 58434
10 GRAPHIC tmb-20250617xdef14a024.jpg GRAPHIC 5660
  Complete submission text file 0001558370-25-006007.txt   4359543

Data Files

Seq Description Document Type Size
11 EX-101.SCH tmb-20250617.xsd EX-101.SCH 4397
12 EX-101.DEF tmb-20250617_def.xml EX-101.DEF 3406
13 EX-101.LAB tmb-20250617_lab.xml EX-101.LAB 5814
14 EX-101.PRE tmb-20250617_pre.xml EX-101.PRE 5000
27 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250617xdef14a_htm.xml XML 530518
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35969 | Film No.: 25895926
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)